Loading clinical trials...
Loading clinical trials...
Intact Potential Symptoms and Biomarker Analysis in Diagnosis of Acid Sphingomyelinase Deficiency (ASMD)
Acid sphingomyelinase Deficiency known as Neiman \_PICK disease is a group of rare genetic diseases. This study includes analysis of clinical manifestations in patients with ASMD and investigations done for diagnosis of these patients
Age
All ages
Sex
ALL
Healthy Volunteers
No
Sohag University Hospital
Sohag, Egypt
Start Date
November 20, 2025
Primary Completion Date
August 10, 2026
Completion Date
September 10, 2026
Last Updated
December 10, 2025
7
ESTIMATED participants
Lead Sponsor
Sohag University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions